Tag: <span>muscular dystrophy</span>

Home / muscular dystrophy
Post

Research discovers inhibitor to reverse toxic DUX4 effects

by University of Minnesota About one in 8,000 people have facioscapulohumeral muscular dystrophy, according to a 2014 study, which is relatively common in the world of genetic diseases. New University of Minnesota Medical School research identifies an inhibitor that protects cells from toxic effects associated with this disease in cells and mice. Facioscapulohumeral muscular dystrophy...

Post

Researchers give new insight to muscular dystrophy patients

New research by University of Minnesota scientists has revealed the three-dimensional structure of the DUX4 protein, which is responsible for the disease, facioscapulohumeral muscular dystrophy (FSHD). Unlike the majority of genetic diseases, FSHD is not caused by a protein that is missing or not functioning properly. Rather it is caused when a functioning, normal, protein...

Post

Tamoxifen and raloxifene slow down the progression of muscular dystrophy

Long-term treatment with selective estrogen receptor modulators (SERMs) improves muscle, respiratory, and skeletal function without weakening bone in new mouse studies, according to a new report in The American Journal of Pathology Philadelphia, March 20, 2018 – Steroids are currently the only available treatment to reduce the repetitive cycles of inflammation and disease progression associated...

Post

Scientists discover ‘internal clock’ inside human cells – paving the way to understanding diseases like muscular dystrophy and cancer

Scientists have found first ‘physical’ measure of a cell’s life stage Method will help researchers study ongoing changes in cells  Findings could shed light on muscular dystrophy and cardiomyopathy  Researchers have discovered the ‘internal clock’ of cells – breaking new ground to understand how diseases take hold of the body. Previously, the biological clock we...

  • 1
  • 3
  • 4